{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:59:28Z","timestamp":1712192368986},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,2]]},"DOI":"10.7759\/cureus.57486","type":"journal-article","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T04:44:33Z","timestamp":1712119473000},"source":"Crossref","is-referenced-by-count":0,"title":["Success in Parenthood: The In Vitro Maturation Breakthrough in Infertility"],"prefix":"10.7759","author":[{"given":"Namrata","family":"Choudhary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarul","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akash","family":"More","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Anjankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepti","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/life11121368","article-title":"The sixth edition of the WHO manual for human semen analysis: a critical review and SWOT analysis","volume":"11","author":"Boitrelle F","year":"2021","unstructured":"Boitrelle F, Shah R, Saleh R, et al.. The sixth edition of the WHO manual for human semen analysis: a critical review and SWOT analysis. Life (Basel). 2021, 11:1368. 10.3390\/life11121368","journal-title":"Life (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s43042-019-0031-4","article-title":"Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: a review","volume":"20","author":"Ashraf S","year":"2019","unstructured":"Ashraf S, Nabi M, Rasool SA, Rashid F, Amin S. Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: a review. EJMHG. 2019, 20:1-10. 10.1186\/s43042-019-0031-4","journal-title":"EJMHG"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2337\/diaspect.28.2.116","article-title":"The role of polycystic ovary syndrome in reproductive and metabolic health: overview and approaches for treatment","volume":"28","author":"Dennett CC","year":"2015","unstructured":"Dennett CC, Simon J. The role of polycystic ovary syndrome in reproductive and metabolic health: overview and approaches for treatment. Diabetes Spectr. 2015, 28:116-20. 10.2337\/diaspect.28.2.116","journal-title":"Diabetes Spectr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.22092\/ARI.2022.358889.2329","article-title":"Polycystic ovary syndrome develops the complications of assisted reproductive technologies","volume":"77","author":"Alhilali MJ","year":"2022","unstructured":"Alhilali MJ, Parham A, Attaranzadeh A, Amirian M, Azizzadeh M. Polycystic ovary syndrome develops the complications of assisted reproductive technologies. Arch Razi Inst. 2022, 77:1459-64. 10.22092\/ARI.2022.358889.2329","journal-title":"Arch Razi Inst"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1600","article-title":"In vitro maturation of oocytes as a laboratory approach to polycystic ovarian syndrome (PCOS): from oocyte to embryo","volume":"15","author":"Rodrigues P","year":"2023","unstructured":"Rodrigues P, Marques M, Manero JA, Marujo MD, Carvalho MJ, Plancha CE. In vitro maturation of oocytes as a laboratory approach to polycystic ovarian syndrome (PCOS): from oocyte to embryo. WIREs Mech Dis. 2023, 15:e1600. 10.1002\/wsbm.1600","journal-title":"WIREs Mech Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5750298","article-title":"The place of in vitro maturation in PCO\/PCOS","volume":"2018","author":"Julania S","year":"2018","unstructured":"Julania S, Walls ML, Hart R. The place of in vitro maturation in PCO\/PCOS. Int J Endocrinol. 2018, 2018:5750298. 10.1155\/2018\/5750298","journal-title":"Int J Endocrinol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2478\/raon-2021-0053","article-title":"In vitro maturation of immature oocytes for fertility preservation in cancer patients compared to control patients with fertility problems in an in vitro fertilization program","volume":"56","author":"Virant-Klun I","year":"2021","unstructured":"Virant-Klun I, Bedenk J, Jancar N. In vitro maturation of immature oocytes for fertility preservation in cancer patients compared to control patients with fertility problems in an in vitro fertilization program. Radiol Oncol. 2021, 56:119-28. 10.2478\/raon-2021-0053","journal-title":"Radiol Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5653\/cerm.2013.40.4.143","article-title":"In vitro maturation: clinical applications","volume":"40","author":"Lim KS","year":"2013","unstructured":"Lim KS, Chae SJ, Choo CW, et al.. In vitro maturation: clinical applications. Clin Exp Reprod Med. 2013, 40:143-7. 10.5653\/cerm.2013.40.4.143","journal-title":"Clin Exp Reprod Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2013.01.090","article-title":"In\u00a0vitro maturation of oocytes: uncommon indications","volume":"99","author":"Grynberg M","year":"2013","unstructured":"Grynberg M, El Hachem H, de Bantel A, Benard J, le Parco S, Fanchin R. In\u00a0vitro maturation of oocytes: uncommon indications. Fertil Steril. 2013, 99:1182-8. 10.1016\/j.fertnstert.2013.01.090","journal-title":"Fertil Steril"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2015(11)09","article-title":"Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice","volume":"70","author":"Melo AS","year":"2015","unstructured":"Melo AS, Ferriani RA, Navarro PA. Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice. Clinics (Sao Paulo). 2015, 70:765-9. 10.6061\/clinics\/2015(11)09","journal-title":"Clinics (Sao Paulo)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064446","article-title":"Recurrent pregnancy loss in polycystic ovary syndrome: role of hyperhomocysteinemia and insulin resistance","volume":"8","author":"Chakraborty P","year":"2013","unstructured":"Chakraborty P, Goswami SK, Rajani S, Sharma S, Kabir SN, Chakravarty B, Jana K. Recurrent pregnancy loss in polycystic ovary syndrome: role of hyperhomocysteinemia and insulin resistance. PLoS One. 2013, 8:e64446. 10.1371\/journal.pone.0064446","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2012.07.001","article-title":"PCOS patients can benefit from in vitro maturation (IVM) of oocytes","volume":"165","author":"Shalom-Paz E","year":"2012","unstructured":"Shalom-Paz E, Holzer H, Son W, Levin I, Tan SL, Almog B. PCOS patients can benefit from in vitro maturation (IVM) of oocytes. Eur J Obstet Gynecol Reprod Biol. 2012, 165:53-6. 10.1016\/j.ejogrb.2012.07.001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2014.05.013","article-title":"In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?","volume":"179","author":"Shavit T","year":"2014","unstructured":"Shavit T, Ellenbogen A, Michaeli M, Kartchovsky E, Ruzov O, Shalom-Paz E. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?. Eur J Obstet Gynecol Reprod Biol. 2014, 179:46-50. 10.1016\/j.ejogrb.2014.05.013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2014.07.019","article-title":"In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome","volume":"29","author":"Das M","year":"2014","unstructured":"Das M, Son WY, Buckett W, Tulandi T, Holzer H. In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome. Reprod Biomed Online. 2014, 29:545-51. 10.1016\/j.rbmo.2014.07.019","journal-title":"Reprod Biomed Online"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-023-01162-x","article-title":"In vitro maturation (IVM) of human immature oocytes: is it still relevant?","volume":"21","author":"Das M","year":"2023","unstructured":"Das M, Son WY. In vitro maturation (IVM) of human immature oocytes: is it still relevant?. Reprod Biol Endocrinol. 2023, 21:110. 10.1186\/s12958-023-01162-x","journal-title":"Reprod Biol Endocrinol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-019-01677-6","article-title":"Live births after oocyte in vitro maturation with a prematuration step in women with polycystic ovary syndrome","volume":"37","author":"Vuong LN","year":"2020","unstructured":"Vuong LN, Le AH, Ho VN, et al.. Live births after oocyte in vitro maturation with a prematuration step in women with polycystic ovary syndrome. J Assist Reprod Genet. 2020, 37:347-57. 10.1007\/s10815-019-01677-6","journal-title":"J Assist Reprod Genet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-6483(10)61101-7","article-title":"In-vitro maturation of immature oocytes for infertile women with PCOS","volume":"8","author":"Chian RC","year":"2004","unstructured":"Chian RC. In-vitro maturation of immature oocytes for infertile women with PCOS. Reprod Biomed Online. 2004, 8:547-52. 10.1016\/S1472-6483(10)61101-7","journal-title":"Reprod Biomed Online"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.06.055","article-title":"Improved implantation and ongoing pregnancy rates after single-embryo transfer with an optimized protocol for in vitro oocyte maturation in women with polycystic ovaries and polycystic ovary syndrome","volume":"98","author":"Junk SM","year":"2012","unstructured":"Junk SM, Yeap D. Improved implantation and ongoing pregnancy rates after single-embryo transfer with an optimized protocol for in vitro oocyte maturation in women with polycystic ovaries and polycystic ovary syndrome. Fertil Steril. 2012, 98:888-92. 10.1016\/j.fertnstert.2012.06.055","journal-title":"Fertil Steril"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/231012-success-in-parenthood-the-in-vitro-maturation-breakthrough-in-infertility","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T04:44:39Z","timestamp":1712119479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/231012-success-in-parenthood-the-in-vitro-maturation-breakthrough-in-infertility"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,2]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.57486","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,2]]}}}